Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax.
作者信息
Lima Keli, Vicari Hugo Passos, Carlos Jorge Antonio Elias Godoy, da Silva Jean Carlos Lipreri, Figueiredo-Pontes Lorena Lobo de, Rego Eduardo Magalhães, Machado-Neto João Agostinho
机构信息
Institute of Biomedical Sciences, Universidade de Sao Paulo, Sao Paulo, SP, Brazil; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Institute of Biomedical Sciences, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
出版信息
Hematol Transfus Cell Ther. 2022 Jan-Mar;44(1):124-127. doi: 10.1016/j.htct.2021.01.004. Epub 2021 Mar 13.
Abstract
摘要
Zotero 插件